Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

TAGAMET HB

CIMETIDINE

Standard Dose
100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Review priority: N/A Marketing status: Discontinued
Summary

Approval overview TAGAMET HB is listed in Drugs@FDA under application 020238 (NDA).

Review priority: N/A Marketing status: Discontinued Active ingredient CIMETIDINE Form and strength TABLET;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor MEDTECH PRODUCTS Submission history Latest submission status date: 2022-05-24 00:00:00.

Structured Monograph

Clinical summary

Approval overview TAGAMET HB is listed in Drugs@FDA under application 020238 (NDA). Review priority: N/A Marketing status: Discontinued Active ingredient CIMETIDINE Form and strength TABLET;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor MEDTECH PRODUCTS Submission history Latest submission status date: 2022-05-24 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: N/A

Interaction Notes

  • No interaction notes stored yet.